| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 174 |
| 1 | METHOTREXATE SODIUM | 159 |
| 2 | ASPIRIN | 155 |
| 3 | DEXAMETHASONE | 154 |
| 4 | DEXAMETHASONE 1.5 MG | 153 |
| 5 | METHOTREXATE | 152 |
| 6 | ASPIRIN 325 MG | 151 |
| 7 | ASPIRIN 81 MG | 151 |
| 8 | ADALIMUMAB | 148 |
| 9 | OMEPRAZOLE MAGNESIUM | 137 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFOTETAN DISODIUM | 2 | 0.0179 |
| 1 | CEFOTETAN | 2 | 0.0150 |
| 2 | HEMIN | 8 | 0.0134 |
| 3 | TRIMIPRAMINE MALEATE | 5 | 0.0126 |
| 4 | GONADOTROPHIN, CHORIONIC | 7 | 0.0113 |
| 5 | BELINOSTAT | 4 | 0.0112 |
| 6 | GANIRELIX ACETATE | 7 | 0.0092 |
| 7 | TOREMIFENE CITRATE | 3 | 0.0070 |
| 8 | CLINDAMYCIN PHOSPHATE | 37 | 0.0067 |
| 9 | INFLIXIMAB-DYYB | 20 | 0.0058 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 515 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 389 |
| 2 | Benzodiazepine [EPC] | 212 |
| 3 | Factor Xa Inhibitor [EPC] | 208 |
| 4 | Platinum-based Drug [EPC] | 169 |
| 5 | Proton Pump Inhibitor [EPC] | 169 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 161 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 159 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 151 |
| 9 | Atypical Antipsychotic [EPC] | 147 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 34 | 0.0058 |
| 1 | Sclerosing Agent [EPC] | 2 | 0.0044 |
| 2 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 3 | Interleukin-36 Receptor Antagonist [EPC] | 1 | 0.0025 |
| 4 | Polyene Antimicrobial [EPC] | 1 | 0.0024 |
| 5 | Human Blood Coagulation Factor [EPC] | 2 | 0.0024 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 20 | 0.0023 |
| 7 | Nucleoside Analog Antifungal [EPC] | 3 | 0.0021 |
| 8 | Catechol-O-Methyltransferase Inhibitor [EPC] | 10 | 0.0020 |
| 9 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 15 | 0.0019 |